Source: Investing.com ↗

Adlai Nortye doses first patient in AN4035 cancer trial

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$85,951.24

-0.10%

ETH/USDT

$2,738.63

-0.21%

ZEC/USDT

$1,611.30

+7.58%

XRP/USDT

$1.60

+3.53%